Invests in
Sectors:
Locations:
Min Investment:
$100,000.00Max Investment:
$5,000,000.00Target Investment:
$1,500,000.00
Skills
Education
MAR (Pending)
Lists including C. Jimmy
Work Experience
2019
Chief Scientific Officer (CSO)
2019
Freenome is an AI genomics company on a mission to empower everyone with the tools they need to detect, treat, and ultimately prevent their diseases. By applying advanced machine learning techniques to recent breakthroughs in genomic science, Freenome is developing noninvasive blood tests to detect early-stage cancer and improve precision oncology treatments for patients everywhere. The company has raised more than $500 million from investors such as Andreessen Horowitz, Google Ventures, Polaris Partners, and Founders Fund.
Venture Partner
2019
We are a new type of seed-stage fund. We believe business is now truly global. Exceptional entrepreneurs, that are building strong, category defining companies at highly advantageous valuations – can be found anywhere. We are a team highly experienced in finding such talent and helping our entrepreneurs to develop, grow, network, and scale into other markets throughout the world.
Founder & Chief Executive Officer (CEO)
2011
We help patients with orphan diseases initiate and fund personalized research projects through a dedicated microfunding platform and highly-selective network of leading academic scientists and commercial institutions.
2015 - 2019
Chief Scientific Officer (CSO), Oncology
2015 - 2019
Natera (NASDAQ: NTRA) is a genetic testing company that develops and commercializes non-invasive methods for analyzing DNA. The mission of the company is to transform the diagnosis and management of genetic disease. In pursuit of that mission, Natera operates a CAP-accredited laboratory certified under the Clinical Laboratory Improvement Amendments (CLIA) in San Carlos, CA. Natera is also applying its unique technologies to develop non-invasive screening and diagnostic tools for earlier detection and improved treatment of cancer - finding circulating DNA (ctDNA) based on liquid biopsy methods.
Advisory Panel on Patient Engagement
2014 - 2018
PCORI is authorized by Congress to conduct research to provide information about the best-available evidence to help patients and their health care providers make better-informed health and healthcare decisions.
2011 - 2017
TED Fellow / Senior Fellow
2011 - 2017
TED Fellows program handpicks world-changing innovators from around the globe and brings them to the TED stage -- literally and figuratively -- to raise international awareness of their remarkable work. http://www.ted.com/pages/ted2012_fellows
ClinOmics: Intramural Clinical Genomics Program
2014 - 2015
2013 - 2014
Entrepreneur in Residence
2013 - 2014
The Mission Center L3C is a think tank for social entrepreneurs, academics, foundations and impact investors who are passionate about finding innovative, business-minded, and sustainable solutions to social problems.
2011 - 2013
Research Instructor
2011 - 2013
2011 - 2012
Visiting Scientist
2011 - 2012